2Azzopardi JG, Chepick OF, Hartmann WH, et al. The World Health Organization histological typing of breast tumors-second edition. Am J Clin Pathol, 1982,78:806-816.
6Nixon AJ, Schnitt SJ, Gelman R, et al. Relationship of tumor grade to other pathologic features and to treatment outcome of patients with early stage breast carcinoma treated with breast-conserving therapy. Cancer, 1996,78:1426-1431.
7Azzopardi JG,et al.Histological lyping of breast tumours.2nd ed,WHO.Geneva 1981.
2Hirata T, Fukuse T, Naiki H, et al. Eepression of CD44 variant exon 6 in stage I non - small cell lung carcinoma as a prognostic factor[J]. Cancer Res, 1998,58(6): 1108 - 1110.
3Ochiais, Nakanishi Y, Mizono K, et al. Expression of CD44 standard and CD44 variant in human lung cancer[J]. Nippon, 1997,35(11): 1179 -1185.·171·
4Culotta E, Koshland J. p53 sweeps through cancer research [J]. Science,1993,262(10) :1958.
5Bae I, Fan S, Bhatia K, et al. Relationships between G1 arrest and stability of the p53 and p21 proteins followingr- irradiation of human lymphoma cells[J]. Cancer Res, 1995,55 (12): 2387.
6Yonish- Rouach E, Resnitzky D, Lotem J,et al. Wild - type p53 induces apoptosis of myeloid leukemic cells that is inhabited by interleukin - 6[J]. Nature, 1991,352(3) :345.
